Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_assertion type Assertion NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_head.
- NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_assertion description "[TAM counts were significantly higher in patients with progressive disease than in those without (p < 0.0001), a trend that remained in patients with known EGFR mutation status (n = 59) and those with wild-type EGFR (n = 20).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_provenance.
- NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_assertion evidence source_evidence_literature NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_provenance.
- NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_assertion SIO_000772 22174092 NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_provenance.
- NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_assertion wasDerivedFrom befree-20150227 NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_provenance.
- NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_assertion wasGeneratedBy ECO_0000203 NP370680.RAeaeSv-nyuTyYQHmo-wc0bDBmxmSacKAn0sLBvSsIpfk130_provenance.